Concepedia

Shriram K. Sundararaman

SK

Statistics

Publications

8

Citations

832

H-Index

8

Active since

2014

Affiliations

Dana-Farber Cancer Institute(Current)

University of Virginia

Brigham and Women's Hospital

Massachusetts Institute of Technology

Brown University

Shriram K. Sundararaman is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and angiogenesis.

ORCID

Top concepts

Publications per year

2014–2022

8

Publications

8

Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer

Shunsuke Kitajima, Elena V. Ivanova, Sujuan Guo et al. · Cancer Discovery · 2018 · 489 citations

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer

Shunsuke Kitajima, Tetsuo Tani, Benjamin F. Springer et al. · Cancer Cell · 2022 · 90 citations · Full text

, , +4

Tumor-Derived cGAMP Regulates Activation of the Vasculature

Marco Campisi, Shriram K. Sundararaman, Sarah E. Shelton et al. · Frontiers in Immunology · 2020 · 56 citations · Full text

, , +18

Frequent somatic <i>TET2</i> mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias

Thomas L. Olson, HeeJin Cheon, Jeffrey C. Xing et al. · Blood · 2021 · 55 citations · Full text

A robust vasculogenic microfluidic model using human immortalized endothelial cells and Thy1 positive fibroblasts

Zhengpeng Wan, Shun Zhang, Amy X. Zhong et al. · Biomaterials · 2021 · 52 citations · Full text

, , +10

1–5 of 8